Department of Medical Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Curr Microbiol. 2023 Apr 8;80(5):175. doi: 10.1007/s00284-023-03247-7.
Klebsiella pneumoniae is an opportunistic bacterium, which is globally recognized for its high prevalence and antimicrobial resistance (AMR). Biofilm-forming capability, susceptibility testing, and phenotypic confirmatory test for extended-spectrum beta-lactamase (ESBL)-producing isolate recognition of 104 K. pneumoniae isolates were performed according to the Clinical Laboratory Standard Institute (CLSI) guidelines. The prevalence of ESBL-associated genes bla-VIM, bla-NDM, and bla-OXA-48, as well as biofilm-associated genes luxS, fimH1, wza, and mrkD, was determined by multiplex PCR. The highest resistance rate was against ampicillin (100.0%). Among the 104 K. pneumoniae isolates, 52 (50.0%) and 31 (29.8%) isolates were determined as multi- and extensively drug resistant (MDR, XDR), respectively. Moreover, 21 (40.4%) isolates were determined as ESBL producing. Among 50 biofilm-producing K. pneumoniae isolates, 7 (14.0%), 15 (30.0%), and 28 (56.0%) isolates exhibited high, moderate, and weak levels of biofilm formation, respectively. A number of 41 (78.8%) isolates were susceptible to colistin, and 10 (19.2%) were resistant. AMR was significantly higher (P < 0.05) in the biofilm-forming isolates compared with non-biofilm formers.
肺炎克雷伯菌是一种机会致病菌,其全球流行率高和对抗生素的耐药性(AMR)受到广泛关注。根据临床实验室标准化研究所(CLSI)指南,对 104 株肺炎克雷伯菌进行了生物膜形成能力、药敏试验和表型确证试验,以确认是否为产超广谱β-内酰胺酶(ESBL)的分离株。采用多重 PCR 法检测 bla-VIM、bla-NDM 和 bla-OXA-48 等 ESBL 相关基因以及 luxS、fimH1、wza 和 mrkD 等生物膜相关基因的流行率。104 株肺炎克雷伯菌对氨苄西林的耐药率最高(100.0%)。在 104 株肺炎克雷伯菌中,52 株(50.0%)和 31 株(29.8%)被确定为多药耐药(MDR)和广泛耐药(XDR),此外,21 株(40.4%)被确定为产 ESBL。在 50 株产生物膜的肺炎克雷伯菌中,7 株(14.0%)、15 株(30.0%)和 28 株(56.0%)的生物膜形成能力分别为高、中、低水平。41 株(78.8%)对黏菌素敏感,10 株(19.2%)耐药。与非生物膜形成株相比,生物膜形成株的 AMR 显著更高(P<0.05)。